Abstract
Mutations in more than 80 genes lead to photoreceptor degeneration. Although subretinal delivery of genes to photoreceptor neurons using AAV vectors has proven itself as an efficient therapeutic and investigative tool in various mouse models, the surgical procedure itself could lead to loss of retinal function even in healthy animals, complicating the interpretation of experimental studies and requiring thoroughly designed controls. A noninvasive approach, such as a systemic delivery of genes with AAV through the bloodstream, may serve as a promising direction in tool development. Previous studies have established that AAV9 is capable of crossing the blood-brain and blood-retina barrier and even has a limited capacity to transduce photoreceptors. AAV-PHP.eB is a novel AAV9-based mutant capsid that crosses the blood-brain barrier and efficiently transduces central nervous system in the adult mice. Here, we investigated its ability to cross the blood-retina barrier and transduce retinal neurons. Control experiments demonstrated virtually nonexisting ability of this capsid to transduce retinal cells via intravitreal administration but high efficiency to transduce photoreceptors via subretinal route. Systemic delivery of AAV-PHP.eB in adult mice robustly transduced horizontal cells throughout the entire retina, but not photoreceptors. Our study suggests that AAV-PHP.eB crosses the intra-retinal blood-retinal barrier (IR-BRB), efficiently transduces horizontal cells located adjacent to IR-BRB, but has very limited ability to further penetrate retina and reach photoreceptors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bemelmans AP, Duque S, Riviere C et al (2013) A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina. PLoS One 8:e61618
Byrne LC, Lin YJ, Lee T et al (2015) The expression pattern of systemically injected AAV9 in the develo** mouse retina is determined by age. Mol Ther 23:290–296
Chan KY, Jang MJ, Yoo BB et al (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 20:1172–1179
Dalkara D, Byrne LC, Lee T et al (2012) Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9. Gene Ther 19:176–181
Dalkara D, Byrne LC, Klimczak RR et al (2013) In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med 5:189ra176
Dinculescu A, Glushakova L, Min SH et al (2005) Adeno-associated virus-vectored gene therapy for retinal disease. Hum Gene Ther 16:649–663
Gruntman AM, Su L, Flotte TR (2017) Retro-orbital venous sinus delivery of rAAV9 mediates high-level transduction of brain and retina compared with temporal vein delivery in neonatal mouse pups. Hum Gene Ther 28:228–230
Kay CN, Ryals RC, Aslanidi GV et al (2013) Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors. PLoS One 8:e62097
Lei B, Zhang K, Yue Y et al (2009) Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer. Mol Vis 15:1374–1382
Petrs-Silva H, Dinculescu A, Li Q et al (2011) Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol Ther 19:293–301
Reid CA, Ertel KJ, Lipinski DM (2017) Improvement of photoreceptor targeting via intravitreal delivery in mouse and human retina using combinatory rAAV2 capsid mutant vectors. Invest Ophthalmol Vis Sci 58:6429–6439
Wang D, Li S, Gessler DJ et al (2018) A rationally engineered capsid variant of AAV9 for systemic CNS-directed and peripheral tissue-detargeted gene delivery in neonates. Mol Ther Methods Clin Dev 9:234–246
Acknowledgments
This study was supported by NIH grants EY030043 (EL) and EY026559 (AD), M2017035 BrightFocus Foundation (AD), University of Florida Startup Funds (ESL and AD), and unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology of the University of Florida.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Simpson, C.P., Bolch, S.N., Zhu, P., Weidert, F., Dinculescu, A., Lobanova, E.S. (2019). Systemic Delivery of Genes to Retina Using Adeno-Associated Viruses. In: Bowes Rickman, C., Grimm, C., Anderson, R., Ash, J., LaVail, M., Hollyfield, J. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 1185. Springer, Cham. https://doi.org/10.1007/978-3-030-27378-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-27378-1_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27377-4
Online ISBN: 978-3-030-27378-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)